1. Home
  2. HSIC vs RGEN Comparison

HSIC vs RGEN Comparison

Compare HSIC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Henry Schein Inc.

HSIC

Henry Schein Inc.

N/A

Current Price

$76.81

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$123.29

Market Cap

8.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HSIC
RGEN
Founded
1932
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.1B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
HSIC
RGEN
Price
$76.81
$123.29
Analyst Decision
Buy
Buy
Analyst Count
14
11
Target Price
$84.50
$173.09
AVG Volume (30 Days)
1.5M
767.3K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
7.21
286.96
EPS
3.27
0.86
Revenue
$13,201,995,000.00
$141,236,000.00
Revenue This Year
$6.15
$14.11
Revenue Next Year
$3.62
$14.71
P/E Ratio
$23.81
$139.37
Revenue Growth
5.94
35.10
52 Week Low
$60.56
$102.97
52 Week High
$89.29
$175.77

Technical Indicators

Market Signals
Indicator
HSIC
RGEN
Relative Strength Index (RSI) 41.69 33.82
Support Level $74.66 $121.25
Resistance Level $79.37 $132.51
Average True Range (ATR) 2.58 6.58
MACD -0.55 -0.05
Stochastic Oscillator 5.18 15.23

Price Performance

Historical Comparison
HSIC
RGEN

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: